兴齐眼药(300573)

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
沈阳兴齐眼药股份有限公司
所属行业
医药制造业
上市日期
2016-12-08
注册资本
24642万元
公司概况
沈阳兴齐眼药股份有限公司的主营业务是眼科药物研发、生产、销售。公司的主要产品是眼科药物。公司先后荣获“辽宁省第九届省长质量奖银奖”、“辽宁五一劳动奖状”、“第十四届中国上市公司投资者关系天马奖”、第二十届“全国质量奖”、“国家级绿色工厂”、第十九届中国上市公司董事会金圆桌“优秀董事会”奖、中国上市公司协会“2024年度上市公司董办优秀实践案例”等奖项荣誉，并入选中国上市公司协会2024年上市公司可持续发展优秀实践案例，在眼科处方药物领域中处于优势地位。
暂无公告

no-quotations

暂不提供行情数据

热议股票

{"pagemeta":{"title":"兴齐眼药(300573)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兴齐眼药(300573)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兴齐眼药,300573,兴齐眼药股票,兴齐眼药股票老虎,兴齐眼药股票老虎国际,兴齐眼药行情,兴齐眼药股票行情,兴齐眼药股价,兴齐眼药股市,兴齐眼药股票价格,兴齐眼药股票交易,兴齐眼药股票购买,兴齐眼药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兴齐眼药(300573)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兴齐眼药(300573)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"300573","data":{"stockData":{"symbol":"300573","market":"SZ","secType":"STK","nameCN":"兴齐眼药","latestPrice":69.18,"timestamp":1770966198000,"preClose":70.15,"halted":0,"volume":4270975,"delay":0,"changeRate":-0.0138,"floatShares":190000000,"shares":246000000,"eps":2.6223,"marketStatus":"已收盘","change":-0.97,"latestTime":"02-13 15:00:00","open":70.5,"high":70.58,"low":69.08,"amount":298000000,"amplitude":0.0214,"askPrice":69.18,"askSize":156,"bidPrice":69.17,"bidSize":149,"shortable":0,"etf":0,"ttmEps":2.6223,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":70.15,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":77.17,"lowLimit":63.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":246429527,"isCdr":false,"pbRate":9.31,"roa":"--","peRate":26.381421,"roe":"32.91%","epsLYR":1.94,"committee":-0.069164,"marketValue":17048000000,"turnoverRate":0.0225,"status":1,"floatMarketCap":13112000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"serverTime":1771707191189,"stockEarnings":[{"period":"1week","weight":-0.0032},{"period":"1month","weight":-0.0855},{"period":"3month","weight":-0.0651},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.3709},{"period":"ytd","weight":-0.0158}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"沈阳兴齐眼药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"54149人(较上一季度增加16.85%)","perCapita":"3500股","listingDate":"2016-12-08","address":"辽宁省沈阳市浑南区中国(辽宁)自由贸易试验区沈阳片区新运河路25号","registeredCapital":"24642万元","survey":"　　沈阳兴齐眼药股份有限公司的主营业务是眼科药物研发、生产、销售。公司的主要产品是眼科药物。公司先后荣获“辽宁省第九届省长质量奖银奖”、“辽宁五一劳动奖状”、“第十四届中国上市公司投资者关系天马奖”、第二十届“全国质量奖”、“国家级绿色工厂”、第十九届中国上市公司董事会金圆桌“优秀董事会”奖、中国上市公司协会“2024年度上市公司董办优秀实践案例”等奖项荣誉，并入选中国上市公司协会2024年上市公司可持续发展优秀实践案例，在眼科处方药物领域中处于优势地位。","listedPrice":5.16}}}}